Literature DB >> 8288325

Acquired immunodeficiency syndrome (AIDS) in multitransfused children with thalassemia.

S Sen1, N M Mishra, T Giri, I Pande, S D Khare, A Kumar, V P Choudhry, D Chattopadhya, S Kumari, A N Malaviya.   

Abstract

Two hundred and three multi-transfused children with thalassemia attending the Thalassemia Clinic of the Charak Palika Hospital, New Delhi were screened for human immunodeficiency virus (HIV) antibodies by ELISA and all positive cases were confirmed by Western Blot. Of the 203 children screened, 18 (8.9%) were HIV positive, and in these children a detailed immunological work up was done and compared to 18 age-matched HIV negative thalassemics as controls. The tests included absolute lymphocyte counts (ALC), absolute and percentages of CD4+ and CD8+ cells and their ratios (CD4/CD8), immunoglobulin levels (IgG, IgM and IgA) and delayed cutaneous hypersensitivity (DCH) test by Multitest CMI in all the cases and the controls. Of the 18 HIV positive children, 6 were diagnosed to have clinical AIDS as per the WHO criteria. After immunological testing, the children were further classified according to the CDC criteria. By these criteria, 11 children were classified as P1 A (asymptomatic infection, normal immune function), 1 child as P1 B (asymptomatic infection, abnormal immune function), 2 children as P2 A (symptomatic infection with non-specific findings), 1 child as P2 C (lymphocytic interstitial pneumonitis), 1 child as P2 D1 (Pneumocystis carinii pneumonia) and 2 children as P2 D2 (symptomatic infection with infections). In this paper, the clinical features of the children with AIDS is described, and the immunologic functions of these children are compared with the HIV positive asymptomatic children and with controls. These are the first cases of AIDS in the pediatric age group from India.

Entities:  

Mesh:

Year:  1993        PMID: 8288325

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  8 in total

1.  Clinico-Immunological Profile of Children Infected with HIV Through Vertical Transmission, in Southern India.

Authors:  Praveen R Shahapur; Indira Bairy
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Transfusion transmitted infections in Indian thalassemics: a perspective.

Authors:  Ajit C Gorakshakar; Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-15       Impact factor: 0.900

3.  Analysis of HIV seropositive thalassemic children for antibodies specific to Aspergillus fumigatus by luminescent immunoassay.

Authors:  G L Sharma; P K Bhatnagar; D Chattopadhya; P U Sarma
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India.

Authors:  Shrivastava Manisha; Kumar Sanjeev; Navaid Seema; Chotrani Dilip; Dwivedi Rashmi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-12       Impact factor: 0.900

Review 5.  Prevention and control of HIV/AIDS.

Authors:  Madhu Choudhry; V P Choudhry
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

6.  Prevalence of pediatric HIV in New Delhi.

Authors:  P Parthasarathy; S K Mittal; V K Sharma
Journal:  Indian J Pediatr       Date:  2006-03       Impact factor: 5.319

7.  Pediatric HIV in Mumbai.

Authors:  Sachee Agrawal; Sandhya Sawant; Jayanthi Shastri
Journal:  Indian J Sex Transm Dis AIDS       Date:  2011-01

8.  Drug-induced reactivation of apoptosis abrogates HIV-1 infection.

Authors:  Hartmut M Hanauske-Abel; Deepti Saxena; Paul E Palumbo; Axel-Rainer Hanauske; Augusto D Luchessi; Tavane D Cambiaghi; Mainul Hoque; Michael Spino; Darlene D'Alliessi Gandolfi; Debra S Heller; Sukhwinder Singh; Myung Hee Park; Bernadette M Cracchiolo; Fernando Tricta; John Connelly; Anthony M Popowicz; Richard A Cone; Bart Holland; Tsafi Pe'ery; Michael B Mathews
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.